The haemodynamic effects of subcutaneous sumatriptan, a 5HT1-receptor agonist

British Journal of Clinical Pharmacology

Volumn 43, Issue 3, 1997, Pages 327-328

  Hood, Stuart ^a,b   Birnie, David ^a   Hillis, Stewart ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

Author keywords

5 hydroxytryptamine; haemodynamics; sumatriptan; vasoconstriction

Indexed keywords

PLACEBO; SEROTONIN AGONIST; SUMATRIPTAN;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; HYPERTENSION; INOTROPISM; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VASOCONSTRICTION;

EID: 0031051121     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1997.00555.x     Document Type: Article

References (6)

1. The Subcutaneous Sumatriptan Derivative International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-321.
2. Brion N, Bons J, Plas J, Bayliss EM, Adverier C. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine. Cephalalgia 1989; 9(suppl 9): 79-82.
3. 1 receptor agonist on haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992; 34: 541-546.
4. 1 agonist on the systemic, pulmonary and coronary circulations. Circulation 1993; 87: 401-405.
5. Jahnel U, Kupp J, Ertl R, Nawrath H. Positive inotropic response to 5HT in human atrial but not in ventricular heart muscle. Naunyn Schmiedebergs Arch Pharmacol 1992; 346: 482-485.
6. Shoemaker RG, Du Xy, Bax WA, Bos E, Saxena PR. 5 Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 1993; 230: 103-105.